Fig 5. Correlation of peptide levels with pro-inflammatory markers in the CSF of patients with relapsing-remitting MS.
The concentration of the indicated biomarkers was examined by MesoScale Discovery technique, and the levels of peptides were quantified by parallel reaction monitoring in the CSF of 17 patients with RRMS.